Berlin Cures Holding AG

Berlin Cures announces changes to Board of Directors to further propel the development of BC 007

Rekrutierung abgeschlossen: Berlin Cures erreicht wichtigen Meilenstein in der Phase-II-Studie mit BC 007 zur Behandlung von Long COVID

Recruitment completed: Berlin Cures achieves key milestone in BC 007 Phase II Trial for treatment of Long COVID

Berlin Cures Expands Research Capabilities and Scientific Expertise with New Advisory Board

Berlin Cures’ BC 007 Targets Long COVID: Solid Phase II Trial Progress with Over 50% Patient Recruitment

Berlin Cures advances fight against Long COVID on a pan-European level

Berlin Cures takes next step in battle against Long COVID

Berlin Cures starts Long COVID Phase II Trial – first patients admitted